accepting new patients

Musa Yilmez, MD

Institution
MD Anderson Cancer Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)

Guillermo Ruiz Arguelles, MD, FRCP, MACP

Institution
Clinica Ruiz
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
About
General Director of Clínica Ruiz, Center of Hematology and Internal Medicine of Puebla; Director of research Division of Laboratorios Ruiz, within Clínica Ruiz; Professor of Hematology at the Autonomous Popular University of the State of Puebla

Hemant Murthy, MD

Institution
Mayo Clinic - Jacksonville
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
About
Hemant S. Murthy M.D., is a Hematology/Oncology physician, with specialty interest in BMT/CAR-T and acute leukemia practice. Dr. Murthy previously served as Assistant Professor of Medicine at the University of Florida College of Medicine in Gainesville, Florida. Prior to joining UF Health, Dr. Murthy was a transplant and cellular immunotherapy fellow at Moffitt Cancer Center.

Joseph Oved, MD

Institution
Memorial Sloan-Kettering Cancer Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Aplastic Anemia
Pediatric
About
Dr. Oved completed scientific and clinical training that included tenures as a Fulbright Fellow with the Weizmann Institute in Israel, the NYU School of Medicine with two years as a Howard Hughes Medical Fellow, followed by a residency in Pediatrics at NYP Weill Cornell Medical College. During his residency, he developed an interest in more translational questions working with Dr. James Bussel to test a novel combination of dexamethasone and rituximab for pediatric patients with chronic idiopathic thrombocytopenic purpura (ITP).

Jacqueline Garcia, MD

Institution
Dana-Farber Cancer Institute
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
About
The focus of Dr. Garcia's research is to develop novel proof-of-concept studies to gain insight on the underlying pathophysiology of acute leukemia and to identify biological predictors of response by partnering with Dana-Farber Cancer Institute laboratory investigators.

Elie Traer, MD, PhD

Institution
OHSU Knight Cancer Institute
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
About
Dr. Traer completed a fellowship in hematology/oncology from Oregon Health & Science University. He received his M.D./Ph.D. from the University of Texas Southwestern Medical School and completed a residency in internal medicine at Oregon Health & Science University. In addition to practicing general hematology at OHSU Knight Cancer Institute, Dr. Traer is involved in clinical trials evaluating targeted therapy with kinase inhibitors in leukemia patients. He is performing research with Brian Druker, M.D. to investigate how the bone marrow microenvironment provides sanctuary to leukemia cells by

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.